Skip to main content
OpenTrials
Completed

NCT Number: NCT06689709

Serum Alkaline Phosphatase Levels In Healthy Turkish Children

Alkaline phosphatase (ALP), is a metalloenzyme of the plasma membrane. Serum ALP levels in children are closely related to age and gender, many commercial test kits being used in hospitals, are only offering reference values for adults. The aim of this study is to determine serum ALP levels regarding to age, gender and pubertal stage.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Alkaline Phosphatase Deficiency Avitaminosis Congenital, Hereditary, and Neonatal Diseases and Abnormalities Deficiency Diseases Genetic Diseases, Inborn Hypophosphatasia Malnutrition Metabolic Diseases Metabolism, Inborn Errors Metal Metabolism, Inborn Errors Nutrition Disorders Nutritional and Metabolic Diseases Vitamin D Deficiency

Age range

14 day–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

Alkaline phosphatase (ALP), is a metalloenzyme of the plasma membrane. Serum ALP levels in children are closely related to age and gender, many commercial test kits being used in hospitals, are only offering reference values for adults. The aim of this study is to determine serum ALP levels regarding to age, gender and pubertal stage Methods: This stuy has been proceeded on children, who have no history for a chronic diseasse or medication and attending to the Keçiören Education and Research Hospital Pediatric Policlinic for routine control between September 2012-September 2013. In order to determine the serum Alkaline Phosphatase levels in children, 1063 (511 male, 552 female) patients were incorporated. Ca, P and vitamin D levels were also evaluated. The ranges of serum ALP levels in both genders according to age has been determined.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy
  • Without chronic diseases

Exclusion criteria

  • With chronic diseases

Treatment and study plan

Serum Alkaline Phosphatase Levels

Other

Venous blood was drawn from the patients

Primary outcomes

  1. Serum Alp Levels In Healthy Turkish Children

    Time frame: 1 year

    mean ALP level was determined for each age and sex and minimum and maximum levels were established.

Secondary outcomes

  1. Vitamin D insufficiency

    Time frame: 1 year

    Regarding their child hood stage, vitamin D insufficiency were established.

Sponsors and collaborators

Lead sponsor

Emine Hafize

Other

Registry information

Official study title

Determination Of Serum Alkaline Phosphatase Levels In Healthy Turkish Children

Important dates

Study start
2013
Primary completion
2014
Study completion
2015
First posted
Nov 14, 2024
Registry last updated
Nov 14, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.